TY - JOUR AU - Grossman, S. A. AU - Ellsworth, S. AU - Campian, J. PY - 2015 DA - 2015// TI - Survival in patients with severe lymphopenia following treatment with radiation and chemotherapy for newly diagnosed solid tumors JO - J Natl Compr Cancer Netw VL - 13 UR - https://doi.org/10.6004/jnccn.2015.0151 DO - 10.6004/jnccn.2015.0151 ID - Grossman2015 ER - TY - JOUR AU - Petrini, B. AU - Wasserman, J. AU - Blomgren, H. PY - 1979 DA - 1979// TI - Blood lymphocyte subpopulations in breast cancer patients following post-operative adjuvant chemotherapy or radiotherapy JO - Clin Exp Immunol VL - 38 ID - Petrini1979 ER - TY - JOUR AU - Wild, A. T. AU - Ye, X. AU - Ellsworth, S. G. PY - 2015 DA - 2015// TI - The association between Chemoradiation-related lymphopenia and clinical outcomes in patients with locally advanced pancreatic adenocarcinoma JO - Am J Clin Oncol VL - 38 UR - https://doi.org/10.1097/COC.0b013e3182940ff9 DO - 10.1097/COC.0b013e3182940ff9 ID - Wild2015 ER - TY - JOUR AU - Wild, A. T. AU - Herman, J. M. AU - Dholakia, A. S. PY - 2016 DA - 2016// TI - Lymphocyte-sparing effect of stereotactic body radiation therapy in patients with Unresectable pancreatic Cancer JO - Int J Radiat Oncol Biol Phys VL - 94 UR - https://doi.org/10.1016/j.ijrobp.2015.11.026 DO - 10.1016/j.ijrobp.2015.11.026 ID - Wild2016 ER - TY - JOUR AU - Grossman, S. A. AU - Ye, X. AU - Lesser, G. PY - 2011 DA - 2011// TI - Immunosuppression in patients with high-grade gliomas treated with radiation and temozolomide JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0774 DO - 10.1158/1078-0432.CCR-11-0774 ID - Grossman2011 ER - TY - JOUR AU - Rudra, S. AU - Hui, C. AU - Rao, Y. J. PY - 2018 DA - 2018// TI - Effect of radiation treatment volume reduction on lymphopenia in patients receiving Chemoradiotherapy for glioblastoma JO - Int J Radiat Oncol Biol Phys VL - 101 UR - https://doi.org/10.1016/j.ijrobp.2018.01.069 DO - 10.1016/j.ijrobp.2018.01.069 ID - Rudra2018 ER - TY - JOUR AU - Huang, J. AU - DeWees, T. A. AU - Badiyan, S. N. PY - 2015 DA - 2015// TI - Clinical and Dosimetric predictors of acute severe lymphopenia during radiation therapy and concurrent Temozolomide for high-grade glioma JO - Int J Radiat Oncol Biol Phys VL - 92 UR - https://doi.org/10.1016/j.ijrobp.2015.04.005 DO - 10.1016/j.ijrobp.2015.04.005 ID - Huang2015 ER - TY - JOUR AU - Yovino, S. AU - Kleinberg, L. AU - Grossman, S. A. PY - 2013 DA - 2013// TI - The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells JO - Cancer Investig VL - 31 UR - https://doi.org/10.3109/07357907.2012.762780 DO - 10.3109/07357907.2012.762780 ID - Yovino2013 ER - TY - JOUR AU - Stupp, R. AU - Mason, W. P. AU - Bent, M. J. PY - 2005 DA - 2005// TI - Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043330 DO - 10.1056/NEJMoa043330 ID - Stupp2005 ER - TY - JOUR AU - Weller, M. AU - Bent, M. AU - Tonn, J. C. PY - 2017 DA - 2017// TI - European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas JO - Lancet Oncol. VL - 18 UR - https://doi.org/10.1016/S1470-2045(17)30194-8 DO - 10.1016/S1470-2045(17)30194-8 ID - Weller2017 ER - TY - JOUR AU - Lee, J. AU - Ahn, S. S. AU - Chang, J. H. PY - 2018 DA - 2018// TI - Hypofractionated re-irradiation after maximal surgical resection for recurrent glioblastoma: therapeutic adequacy and its prognosticators of survival JO - Yonsei Med J VL - 59 UR - https://doi.org/10.3349/ymj.2018.59.2.194 DO - 10.3349/ymj.2018.59.2.194 ID - Lee2018 ER - TY - JOUR AU - Lim, M. AU - Xia, Y. AU - Bettegowda, C. PY - 2018 DA - 2018// TI - Current state of immunotherapy for glioblastoma JO - Nat Rev Clin Oncol VL - 15 UR - https://doi.org/10.1038/s41571-018-0003-5 DO - 10.1038/s41571-018-0003-5 ID - Lim2018 ER - TY - JOUR AU - Gupta, T. AU - Mohanty, S. AU - Moiyadi, A. PY - 2013 DA - 2013// TI - Factors predicting temozolomide induced clinically significant acute hematologic toxicity in patients with high-grade gliomas: a clinical audit JO - Clin Neurol Neurosurg VL - 115 UR - https://doi.org/10.1016/j.clineuro.2013.05.015 DO - 10.1016/j.clineuro.2013.05.015 ID - Gupta2013 ER - TY - JOUR AU - Choi, S. H. AU - Kim, J. W. AU - Chang, J. S. PY - 2017 DA - 2017// TI - Impact of including Peritumoral edema in radiotherapy target volume on patterns of failure in glioblastoma following Temozolomide-based Chemoradiotherapy JO - Sci Rep VL - 7 UR - https://doi.org/10.1038/srep42148 DO - 10.1038/srep42148 ID - Choi2017 ER - TY - JOUR AU - Lim, D. A. AU - Cha, S. AU - Mayo, M. C. PY - 2007 DA - 2007// TI - Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype JO - Neuro-Oncology VL - 9 UR - https://doi.org/10.1215/15228517-2007-023 DO - 10.1215/15228517-2007-023 ID - Lim2007 ER - TY - STD TI - Carr D, ported by Nicholas Lewin-Koh, Martin Maechler and contains copies of latticefunction written by Deepayan Sarkar: Hexbin: hexagonal binning routines. Package version 1.27.0. http://CRAN.R-project.org/package=hexbin. (2014). UR - http://cran.r-project.org/package=hexbin ID - ref16 ER - TY - JOUR AU - Ho KI, D. AU - King, G. AU - Stuart, E. A. PY - 2011 DA - 2011// TI - MatchIt: nonparametric preprocessing for parametric causal inference JO - J Stat Softw VL - 42 ID - Ho KI2011 ER - TY - JOUR AU - Gramatzki, D. AU - Dehler, S. AU - Rushing, E. J. PY - 2016 DA - 2016// TI - Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009 JO - Cancer. VL - 122 UR - https://doi.org/10.1002/cncr.30023 DO - 10.1002/cncr.30023 ID - Gramatzki2016 ER - TY - JOUR AU - Weller, M. AU - Cloughesy, T. AU - Perry, J. R. PY - 2013 DA - 2013// TI - Standards of care for treatment of recurrent glioblastoma--are we there yet? JO - Neuro-Oncology VL - 15 UR - https://doi.org/10.1093/neuonc/nos273 DO - 10.1093/neuonc/nos273 ID - Weller2013 ER - TY - JOUR AU - Coussens, L. M. AU - Werb, Z. PY - 2002 DA - 2002// TI - Inflammation and cancer JO - Nature. VL - 420 UR - https://doi.org/10.1038/nature01322 DO - 10.1038/nature01322 ID - Coussens2002 ER - TY - JOUR AU - Tran, C. AU - Knowles, S. R. AU - Liu, B. A. PY - 1998 DA - 1998// TI - Gender differences in adverse drug reactions JO - J Clin Pharmacol VL - 38 UR - https://doi.org/10.1177/009127009803801103 DO - 10.1177/009127009803801103 ID - Tran1998 ER - TY - JOUR AU - Nakamura, N. AU - Kusunoki, Y. AU - Akiyama, M. PY - 1990 DA - 1990// TI - Radiosensitivity of CD4 or CD8 positive human T-lymphocytes by an in vitro colony formation assay JO - Radiat Res VL - 123 UR - https://doi.org/10.2307/3577549 DO - 10.2307/3577549 ID - Nakamura1990 ER - TY - JOUR AU - Narayana, A. AU - Yamada, J. AU - Berry, S. PY - 2006 DA - 2006// TI - Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results JO - Int J Radiat Oncol Biol Phys VL - 64 UR - https://doi.org/10.1016/j.ijrobp.2005.05.067 DO - 10.1016/j.ijrobp.2005.05.067 ID - Narayana2006 ER - TY - JOUR AU - Chen, A. B. PY - 2014 DA - 2014// TI - Comparative effectiveness research in radiation oncology: assessing technology JO - Semin Radiat Oncol VL - 24 UR - https://doi.org/10.1016/j.semradonc.2013.08.003 DO - 10.1016/j.semradonc.2013.08.003 ID - Chen2014 ER - TY - JOUR AU - Nutting, C. M. AU - Morden, J. P. AU - Harrington, K. J. PY - 2011 DA - 2011// TI - Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(10)70290-4 DO - 10.1016/S1470-2045(10)70290-4 ID - Nutting2011 ER - TY - JOUR AU - Liu, L. T. AU - Chen, Q. Y. AU - Tang, L. Q. PY - 2018 DA - 2018// TI - The prognostic value of treatment-related lymphopenia in nasopharyngeal carcinoma patients JO - Cancer Res Treat VL - 50 UR - https://doi.org/10.4143/crt.2016.595 DO - 10.4143/crt.2016.595 ID - Liu2018 ER - TY - JOUR AU - Lohr, J. AU - Ratliff, T. AU - Huppertz, A. PY - 2011 DA - 2011// TI - Effector T-cell infiltration positively impacts survival of glioblastoma patients and is impaired by tumor-derived TGF-beta JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2557 DO - 10.1158/1078-0432.CCR-10-2557 ID - Lohr2011 ER - TY - JOUR AU - Gooden, M. J. AU - Bock, G. H. AU - Leffers, N. PY - 2011 DA - 2011// TI - The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis JO - Br J Cancer VL - 105 UR - https://doi.org/10.1038/bjc.2011.189 DO - 10.1038/bjc.2011.189 ID - Gooden2011 ER - TY - JOUR AU - Campian, J. L. AU - Sarai, G. AU - Ye, X. PY - 2014 DA - 2014// TI - Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer JO - Head Neck VL - 36 UR - https://doi.org/10.1002/hed.23535 DO - 10.1002/hed.23535 ID - Campian2014 ER - TY - JOUR AU - Venkatesulu, B. P. AU - Mallick, S. AU - Lin, S. H. PY - 2018 DA - 2018// TI - A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors JO - Crit Rev Oncol Hematol VL - 123 UR - https://doi.org/10.1016/j.critrevonc.2018.01.003 DO - 10.1016/j.critrevonc.2018.01.003 ID - Venkatesulu2018 ER - TY - JOUR AU - Jafri, N. F. AU - Clarke, J. L. AU - Weinberg, V. PY - 2013 DA - 2013// TI - Relationship of glioblastoma multiforme to the subventricular zone is associated with survival JO - Neuro-Oncology VL - 15 UR - https://doi.org/10.1093/neuonc/nos268 DO - 10.1093/neuonc/nos268 ID - Jafri2013 ER - TY - JOUR AU - Yan, H. AU - Parsons, D. W. AU - Jin, G. PY - 2009 DA - 2009// TI - IDH1 and IDH2 mutations in gliomas JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0808710 DO - 10.1056/NEJMoa0808710 ID - Yan2009 ER - TY - JOUR AU - Hegi, M. E. AU - Diserens, A. C. AU - Gorlia, T. PY - 2005 DA - 2005// TI - MGMT gene silencing and benefit from temozolomide in glioblastoma JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa043331 DO - 10.1056/NEJMoa043331 ID - Hegi2005 ER -